SD BIOSENSOR INC.
KOSPI-listed in-vitro diagnostics company known for the STANDARD Q antigen/antibody test kits.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 2010 and listed on KOSPI in 2021, SD Biosensor is an in-vitro diagnostics (IVD) medical device and reagent company. It combines immunoassay, molecular, and clinical chemistry technology platforms into a portfolio addressing infectious disease and chronic disease diagnostics, with products including the STANDARD Q antigen/antibody test kits. Based on global certifications such as WHO PQ, CE-IVD/IVDR, and FDA, it supplies both commercial markets and international public procurement channels such as the Global Fund and UNICEF.
Products & technology
- STANDARD Q antigen/antibody test kitIn-vitro diagnostic test for infectious diseases including COVID-19
Regulatory approvals
data.go.kr · openFDA447 Korean MFDS device approvals · 2007–2026 / 4 US FDA 510(k) · 2015–2017
- MFDSChemiluminescence assay(CLIA) analyzer2026-08-14Product approval · Class 1체외 제신 26-1015 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2026-08-05Product approval · Class 3체외 제허 26-597 호
- MFDSIVD Reagents for pregnancy/childbirth hormone and protein tests2026-07-28Product approval · Class 2체외 제인 26-4695 호
- MFDSCentrifugal clinical chemistry automated analyser2026-07-24Product approval · Class 1체외 수신 26-1645 호
- MFDSUrine chemistry analyzer, (semi-)automated2026-07-03Product approval · Class 1체외 수신 26-1476 호
- MFDSUrine chemistry analyzer, (semi-)automated2026-07-03Product approval · Class 1체외 수신 26-1475 호
- MFDSIVD reagents for vitamin tests2026-06-16Product approval · Class 2체외 제인 26-4526 호
- MFDSIVD reagents for diabetes mellitus2026-05-19Product approval · Class 2체외 수인 26-4351 호
- MFDSIVD Reagents for pregnancy/childbirth hormone and protein tests2026-05-19Product approval · Class 2체외 제인 26-4444 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2026-05-15Product approval · Class 3체외 제허 26-366 호
- MFDSHematology analyzer, glycohemoglobin2026-05-14Product approval · Class 1체외 수신 26-1038 호
- MFDSIVD Reagents for pregnancy/childbirth hormone and protein tests2026-05-11Product approval · Class 2체외 제인 26-4419 호
Show 68 more
- MFDSIVD Reagents for thyroid function hormone tests2026-04-30Product approval · Class 2체외 제인 26-4389 호
- MFDSIVD reagents for kidney metabolite measurement test2026-04-27Product approval · Class 2체외 제인 26-4369 호
- MFDSIVD reagents for diabetes mellitus2026-04-22Product approval · Class 2체외 제인 26-4355 호
- MFDSIVD reagents for bone and mineral metabolite measurement test2026-04-20Product approval · Class 2체외 제인 26-4343 호
- MFDSIVD reagents for diabetes mellitus2026-04-16Product approval · Class 2체외 수인 26-4261 호
- MFDSIVD Reagents for thyroid function hormone tests2026-04-09Product approval · Class 2체외 제인 26-4324 호
- MFDSIVD Reagents for thyroid function hormone tests2026-04-09Product approval · Class 2체외 제인 26-4323 호
- MFDSIVD Reagents for thyroid function hormone tests2026-04-09Product approval · Class 2체외 제인 26-4322 호
- MFDSIVD Reagents for pregnancy/childbirth hormone and protein tests2026-04-09Product approval · Class 2체외 제인 26-4320 호
- MFDSIVD Reagents for pregnancy/childbirth hormone and protein tests2026-03-16Product approval · Class 2체외 제인 26-4241 호
- MFDSIVD Reagents for pregnancy/childbirth hormone and protein tests2026-03-13Product approval · Class 2체외 제인 26-4239 호
- MFDSIVD Reagents for thyroid function hormone tests2026-03-12Product approval · Class 2체외 제인 26-4228 호
- MFDSIVD Reagents for pregnancy/childbirth hormone and protein tests2026-03-12Product approval · Class 2체외 제인 26-4226 호
- MFDSIVD Reagents for pregnancy/childbirth hormone and protein tests2026-03-12Product approval · Class 2체외 제인 26-4225 호
- MFDSHematology analyzer, glycohemoglobin2026-02-24Product approval · Class 1체외 수신 26-428 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2026-02-23Product approval · Class 3체외 제허 26-144 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2026-02-02Product approval · Class 3체외 제허 26-98 호
- MFDSIVD reagents for infectious inflammatory tests2026-01-30Product approval · Class 2체외 제인 26-4093 호
- MFDSIVD Reagents for pregnancy/childbirth hormone and protein tests2026-01-28Product approval · Class 2체외 제인 26-4089 호
- MFDSContinuous glucose monitoring systems, self-testing, in vivo2026-01-08Product approval · Class 3제허 26-21 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2025-12-29Product approval · Class 3체외 제허 25-867 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2025-12-16Product approval · Class 3체외 제허 25-842 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2025-11-18Product approval · Class 3체외 제허 25-776 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2025-11-11Product approval · Class 3체외 제허 25-760 호
- MFDSIVD reagents for Infectious disease marker(Detection of low infectivity pathogen), nucleic acid test2025-09-16Product approval · Class 2체외 제인 25-4876 호
- MFDSIVD reagents for allergy test2025-09-15Product approval · Class 2체외 제인 25-4873 호
- MFDSIVD reagents for cardiac marker2025-09-10Product approval · Class 3체외 제허 25-621 호
- MFDSIVD reagents for cardiac markerRevoked2025-09-10Product approval · Class 3체외 제허 25-620 호
- MFDSGeneral Calibrators, controls or standards, classⅢ, for clinical immunology, not a component of specific kit, wide use2025-09-08Product approval · Class 3체외 제허 25-616 호
- MFDSIVD Reagents for pregnancy/childbirth hormone and protein testsRevoked2025-09-03Product approval · Class 2체외 제인 25-4818 호
- MFDSIVD Reagents for thyroid function hormone testsRevoked2025-09-03Product approval · Class 2체외 제인 25-4817 호
- MFDSIVD Reagents for thyroid function hormone testsRevoked2025-09-03Product approval · Class 2체외 제인 25-4816 호
- MFDSCapillary blood collection tube2025-08-27Product approval · Class 1수신 25-1864 호
- MFDSCapillary blood collection tube2025-08-25Product approval · Class 1수신 25-1840 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2025-08-08Product approval · Class 3체외 제허 25-545 호
- MFDSIVD reagents for Infectious disease marker(Drug resistant microorganism)2025-08-06Product approval · Class 3체외 제허 25-537 호
- MFDSCapillary blood collection tube2025-07-25Product approval · Class 1수신 25-1609 호
- MFDSCapillary blood collection tube2025-07-22Product approval · Class 1수신 25-1585 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2025-07-21Product approval · Class 3체외 제허 25-489 호
- MFDSTool for specimens2025-07-17Product approval · Class 1수신 25-1547 호
- MFDSIVD reagents for tumor marker2025-07-16Product approval · Class 3체외 제허 25-472 호
- MFDSIVD reagents for cardiac marker2025-07-15Product approval · Class 3체외 제허 25-468 호
- MFDSIVD reagents for tumor marker2025-07-15Product approval · Class 3체외 제허 25-467 호
- MFDSIVD Reagents for pregnancy/childbirth hormone and protein testsRevoked2025-07-09Product approval · Class 2체외 제인 25-4609 호
- MFDSIVD reagents for tumor marker2025-07-07Product approval · Class 3체외 제허 25-445 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2025-07-03Product approval · Class 3체외 제허 25-438 호
- MFDSIVD reagents for tumor marker2025-06-26Product approval · Class 3체외 제허 25-416 호
- MFDSIVD reagents for cardiac marker2025-06-26Product approval · Class 3체외 제허 25-415 호
- MFDSIVD Reagents for pregnancy/childbirth hormone and protein testsRevoked2025-06-23Product approval · Class 2체외 제인 25-4549 호
- MFDSIVD Reagents for pregnancy/childbirth hormone and protein testsRevoked2025-06-23Product approval · Class 2체외 제인 25-4548 호
- MFDSIVD reagents for infectious inflammatory testsRevoked2025-06-20Product approval · Class 2체외 제인 25-4546 호
- MFDSIVD reagents for tumor marker2025-06-16Product approval · Class 3체외 제허 25-391 호
- MFDSIVD reagents for cardiac marker2025-06-16Product approval · Class 3체외 제허 25-390 호
- MFDSIVD reagents for anemia testRevoked2025-06-13Product approval · Class 2체외 제인 25-4511 호
- MFDSIVD Reagents for thyroid function hormone testsRevoked2025-06-12Product approval · Class 2체외 제인 25-4507 호
- MFDSIVD Reagents for pregnancy/childbirth hormone and protein testsRevoked2025-06-12Product approval · Class 2체외 제인 25-4506 호
- MFDSLancet, automatic, single-use2025-04-23Product approval · Class 2수인 25-4246 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnosticsRevoked2025-04-17Product approval · Class 3체외 제허 25-256 호
- MFDSIVD strip for endocrine self test2025-04-14Product approval · Class 2체외 수인 25-4230 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2025-04-02Product approval · Class 3체외 제허 25-217 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2025-01-13Product approval · Class 3체외 제허 25-24 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2025-01-10Product approval · Class 3체외 제허 25-18 호
- MFDSChemiluminescence assay(CLIA) analyzer2024-11-26Product approval · Class 1체외 제신 24-1470 호
- MFDSChemiluminescence assay(CLIA) analyzer2024-11-26Product approval · Class 1체외 제신 24-1469 호
- MFDSIVD reagents for diagnosis of HIV, HBV, HCV, HTLV, immunological method2024-11-12Product approval · Class 4체외 제허 24-780 호
- MFDSIVD Reagents for pregnancy/childbirth hormone and protein tests2024-09-30Product approval · Class 2체외 제인 24-901 호
- MFDSIVD reagents for anemia test2024-09-30Product approval · Class 2체외 제인 24-900 호
- MFDSIVD strip for glucose self test2024-09-12Product approval · Class 3체외 제허 24-633 호
Showing the 80 most recent of 451 records.
AI reads
MAA server logs · IP-verifiedSomeone asked an AI a question, and it fetched this page live to answer.
Collected for later use. Not a signal of interest.
- OpenAIOAI-SearchBot2
Measured since Aug 25, 2026 · 1 AI engines · last read Aug 25, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS.
Companies approved for the same productsBiotech & Drug Discovery
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.
KOSDAQ-listed point-of-care immunodiagnostics company supplying diagnostic cartridges and the ichroma/AFIAS instrument series.
Founded 1996, listed on KOSDAQ in 2024, OSANG HEALTHCARE develops and sells biochemistry, immunodiagnostic, and molecular IVD products.
Founded in 2011 and KOSDAQ-listed in 2019, Sugentech develops multiplex immunoblot, point-of-care, and digital healthcare diagnostics.
KOSDAQ-listed IVD company producing COVID-19 and HIV point-of-care diagnostic reagents alongside rubber products and entertainment businesses.
Founded in 2000 and KOSDAQ-listed in 2013, i-SENS makes blood glucose monitors and point-of-care testing devices.
Founded in 1987 and listed on KOSDAQ in 2000, NanoenTek develops Lab-On-a-Chip in-vitro diagnostic devices and life science instruments.
KOSDAQ-listed IVD company producing time-resolved fluorescence immunodiagnostic products under the Exdia TRF brand.
Holds manufacturing approvals for 42 point-of-care diagnostic reagents and devices in the IVD market.
KOSDAQ-listed IVD company using SG Cap™ multiplex diagnostic technology for infectious disease, cancer, and companion animal testing.
KOSDAQ-listed in-vitro diagnostics company developing the LabChip-based VERI-Q molecular diagnostic device series.
KOSDAQ-listed biotech company developing molecular diagnostics with proprietary C-Tag technology and the NeoPlex product line.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition